BHF is the representative organisation for the majority of medical schemes throughout South Africa, Namibia, Zimbabwe, Botswana as well as Lesotho. As the industry representative body, the organisation relies on the membership of all medical schemes to ensure that it is able to lobby government and other organisations effectively and to influence policy where necessary on behalf of the entire industry. Read more..


We are delighted to announce the dates for the 16th Annual BHF Southern African Conference. The event will be held from the 26th to the 29th of July 2015 at the CTICC in Cape Town.


BHF Website

Our website is being renovated in preparation of moving to our new site. In the interim should you require a document that is not on our current site please contact laurab@bhfglobal.com

We look forward to welcoming you to the BHF's new site.

BHF Trustee Training: 2015:

This focused, comprehensive, one-day course provides in-depth information on the key areas relating to good governance of medical schemes. Highly relevant to trustees and those working within the private funding sector.

The topics are presented by industry experts and all delegates receive a CD with resource manual containing relevant information as well as a bound copy of the Medical Schemes Act and Regulations.

We will be posting the dates of the 2015 Training sessions soon.

Please contact heidik@bhfglobal.com for information regarding future Trustee Training sessions, as well as customized sessions.


2013 BHF Annual Report

The 2013 BHF Annual Report was presented at the AGM held at the Durban International Conference Centre on the 26th of August 2014. Click here to view the Annual Report.



Hospital providers still looking healthy

Andile Makholwa: Financial Mail, 27 November 2014

DESPITE stagnant growth in the medical aid population, SA's listed private healthcare providers continue to report double digit growth figures. Results posted by Mediclinic, Life Healthcare and Netcare were an early Christmas present for investors in these stocks.

Ebola vaccine promising in first human trials

Jean-Louis Santini: AFP, 26 November 2014

RESEARCHERS say they are a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

HIV/AIDS infections in numbers

Andile Makholwa: Source: UNAIDS: Financial Mail, 27 November 2014

34m people worldwide were living with HIV in 2013.
24,7m HIV-positive people live in Sub-Saharan Africa.

Northern exposure

Stephen Cranston: Financial Mail, 27 November 2014

PRUDENTIAL has one of the strongest brands in the UK and Discovery knew, after the failure of its US start-up, Destiny Health, it needed a strong brand to succeed in the competitive UK private medical insurance market.

First gene therapy drug sets price record

Reuters: 27 November 2014

THE Western world's first gene therapy drug is set to go on sale in Germany with a €1.1m ($1.4m) price tag, a new record for a medicine to treat a rare disease.

Copyright © 1999 - 2007 Board of Healthcare Funders of Southern Africa. Client Services: 0861 30 20 10
All rights reserved. User Agreement.